Researchers at the ICN2 and the UAB have developed a novel strategy to obtain different types of organic molecules by ...

The tribunal noted that all these stakeholders must explain their role, responsibility and steps taken (or lack thereof) to ...

COLUMBUS, OHIO — In a call to action regarding the societal role of meat scientists, Keith Belk, PhD, head of the Department ...

TSMC has achieved a 60% yield in its 2-nanometer manufacturing process, according to reports from local Taiwanese media. Yield refers to the efficienc. We've just launched our NEW website design!

This innovative solution generated timely readiness for the ship ahead of its planned patrol throughout U.S. Sixth Fleet. Expediting the process, the Naval Sea Systems Command (NAVSEA) engineering ...

A semi-automated process has been developed for manufacturing MOEMS-EC-QCL modules, significantly reducing production complexity and cost.

– Proprietary manufacturing process enables robust and scalable GMP-compliant manufacture of autologous engineered RMT products, including lead asset RTX001 in end-stage liver disease (ESLD). – Novel ...

An Austrian consortium reports that they’ve developed the world’s first fully integrated and automated process for producing recombinant proteins using E.coli.Recombinant protein manufacturer ...

Changes to the 737 production process are starting to bear fruit as output rises and mistakes decline. Credit: Sean Broderick/AW&ST Amid rising global economic uncertainty, nagging supply chain ...

Intel said on Tuesday that several of its contract manufacturing customers planned to build test chips for a forthcoming advanced manufacturing process, which the company still has in development.

RMC-9805-001 is a multicenter, open-label, dose escalation and dose-expansion Phase 1 study designed to evaluate zoldonrasib in patients with advanced solid tumors harboring a KRAS G12D mutation. As ...

RMC-9805-001 is a multicenter, open-label, dose escalation and dose-expansion Phase 1 study designed to evaluate zoldonrasib in patients with advanced solid tumors harboring a KRAS G12D mutation.